ADITXT INC (ADTX) Fundamental Analysis & Valuation
NASDAQ:ADTX • US0070258779
Current stock price
0.2169 USD
0 (-0.73%)
At close:
0.2103 USD
-0.01 (-3.04%)
After Hours:
This ADTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ADTX Profitability Analysis
1.1 Basic Checks
- In the past year ADTX has reported negative net income.
- ADTX had a negative operating cash flow in the past year.
- ADTX had negative earnings in each of the past 5 years.
- In the past 5 years ADTX always reported negative operating cash flow.
1.2 Ratios
- ADTX has a Return On Assets of -260.95%. This is amonst the worse of the industry: ADTX underperforms 92.04% of its industry peers.
- Looking at the Return On Equity, with a value of -768.34%, ADTX is doing worse than 80.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -260.95% | ||
| ROE | -768.34% | ||
| ROIC | N/A |
ROA(3y)-153.28%
ROA(5y)-199.13%
ROE(3y)-475.65%
ROE(5y)-482.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ADTX has a better Gross Margin (9.38%) than 70.10% of its industry peers.
- In the last couple of years the Gross Margin of ADTX has declined.
- ADTX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.38% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.95%
GM growth 5YN/A
2. ADTX Health Analysis
2.1 Basic Checks
- ADTX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- ADTX has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for ADTX has been increased compared to 5 years ago.
- The debt/assets ratio for ADTX has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -22.29, we must say that ADTX is in the distress zone and has some risk of bankruptcy.
- ADTX has a worse Altman-Z score (-22.29) than 85.63% of its industry peers.
- A Debt/Equity ratio of 0.33 indicates that ADTX is not too dependend on debt financing.
- ADTX has a Debt to Equity ratio of 0.33. This is in the lower half of the industry: ADTX underperforms 70.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -22.29 |
ROIC/WACCN/A
WACC49.19%
2.3 Liquidity
- ADTX has a Current Ratio of 0.31. This is a bad value and indicates that ADTX is not financially healthy enough and could expect problems in meeting its short term obligations.
- ADTX's Current ratio of 0.31 is on the low side compared to the rest of the industry. ADTX is outperformed by 94.17% of its industry peers.
- ADTX has a Quick Ratio of 0.31. This is a bad value and indicates that ADTX is not financially healthy enough and could expect problems in meeting its short term obligations.
- ADTX's Quick ratio of 0.31 is on the low side compared to the rest of the industry. ADTX is outperformed by 93.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.31 | ||
| Quick Ratio | 0.31 |
3. ADTX Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 90.47% over the past year.
- The Revenue for ADTX has decreased by -97.61% in the past year. This is quite bad
- Measured over the past years, ADTX shows a very negative growth in Revenue. The Revenue has been decreasing by -84.90% on average per year.
EPS 1Y (TTM)90.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.81%
Revenue 1Y (TTM)-97.61%
Revenue growth 3Y-84.9%
Revenue growth 5YN/A
Sales Q2Q%-87.5%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ADTX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ADTX. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. ADTX Dividend Analysis
5.1 Amount
- ADTX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ADTX Fundamentals: All Metrics, Ratios and Statistics
0.2169
0 (-0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength54.66
Industry Growth13.04
Earnings (Last)03-31 2026-03-31/bmo
Earnings (Next)05-13 2026-05-13
Inst Owners0.5%
Inst Owner Change-100%
Ins Owners2.16%
Ins Owner Change4.88%
Market Cap195.21K
Revenue(TTM)3.20K
Net Income(TTM)-43.10M
Analysts80
Price TargetN/A
Short Float %16.81%
Short Ratio0.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 61 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | N/A |
EPS(TTM)-14999.65
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-28.56
FCFYN/A
OCF(TTM)-28.54
OCFYN/A
SpS0
BVpS6.23
TBVpS6.23
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -260.95% | ||
| ROE | -768.34% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.38% | ||
| FCFM | N/A |
ROA(3y)-153.28%
ROA(5y)-199.13%
ROE(3y)-475.65%
ROE(5y)-482.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.95%
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 5.03% | ||
| Cap/Sales | 428.13% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.31 | ||
| Quick Ratio | 0.31 | ||
| Altman-Z | -22.29 |
F-Score4
WACC49.19%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-97.61%
Revenue growth 3Y-84.9%
Revenue growth 5YN/A
Sales Q2Q%-87.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.25%
OCF growth 3YN/A
OCF growth 5YN/A
ADITXT INC / ADTX Fundamental Analysis FAQ
What is the fundamental rating for ADTX stock?
ChartMill assigns a fundamental rating of 1 / 10 to ADTX.
Can you provide the valuation status for ADITXT INC?
ChartMill assigns a valuation rating of 0 / 10 to ADITXT INC (ADTX). This can be considered as Overvalued.
What is the profitability of ADTX stock?
ADITXT INC (ADTX) has a profitability rating of 1 / 10.
Can you provide the financial health for ADTX stock?
The financial health rating of ADITXT INC (ADTX) is 1 / 10.